Parkizol (pramipexole dihydrochloride monohydrate) tablets 0.25 mg. №30


Manufacturer: India



Treatment of symptoms of idiopathic Parkinson’s disease in adults as monotherapy (without levodopa) or in combination with levodopa during the course of the disease until the later stages, when the effect of levodopa decreases or becomes unstable and there is a fluctuation in the therapeutic effect (the phenomenon of “Inclusion-exclusion”). Symptomatic treatment of moderate to severe idiopathic restless leg syndrome in adults at doses no higher than 0.75 mg.